An insane thing to do while not quite sound of mind you may think – and you’d be right, because it was during one such ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Researchers estimate that 123,000 to 193,000 U.S. adults were hospitalized each year with respiratory syncytial virus from ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...

About 35% of adults got a flu shot, while 18% received the updated COVID-19 vaccine by early November, the CDC report said.

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

When should pregnant women get the RSV vaccine? Research suggests that 32 weeks into pregnancy ensures the best antibody ...

Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

Seasonal maternal respiratory syncytial virus vaccination and nirsevimab for infants demonstrate cost-effectiveness.

PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced new preliminary data for AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) in adults aged 18-49 at increased risk for ...